Related Experiment Video

Updated: Aug 7, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells

Suparna Qanungo1, Aruna Basu, Madhusudan Das

  • 1Department of Research, Pharmacology, Ireland Cancer Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, OH 44109, USA.

Oncogene
|May 31, 2002
PubMed

Insights

2-methoxyestradiol (2-ME) exhibits antiproliferative effects on pancreatic cancer cells by inducing apoptosis. Differential responses were observed, with some cell lines undergoing apoptosis via G2-M arrest or G1-S accumulation, highlighting potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • 2-methoxyestradiol (2-ME), an endogenous estrogen metabolite, demonstrates antiproliferative activity against cancer cells.
  • The precise downstream molecular mechanisms driving 2-ME-induced apoptosis remain largely uncharacterized.

Purpose of the Study:

  • To investigate the effects of 2-ME on apoptosis in human pancreatic cancer cell lines.
  • To identify differential responses and elucidate the signaling pathways involved in 2-ME-induced cell death.

Main Methods:

  • Exposure of human pancreatic cancer cell lines (MIA PaCa-2, CFPAC-1, PANC-1, Hs 766T) to 2-ME.
  • Cell cycle analysis (G1-S, G2-M arrest, tetraploid cell accumulation).
  • Mitochondrial-dependent apoptosis assays (cytochrome c release, Bid cleavage, Bax translocation), and Western blotting for Bcl-x(L) phosphorylation.

Main Results:

  • Pancreatic cancer cell lines exhibited differential sensitivity to 2-ME, categorizing them into sensitive (MIA PaCa-2, CFPAC-1, PANC-1) and non-sensitive (Hs 766T) groups.
  • Sensitive cell lines underwent apoptosis through distinct mechanisms: G2-M arrest with Bcl-x(L) phosphorylation (PANC-1) or G1-S accumulation without Bcl-2/Bcl-x(L) phosphorylation (MIA PaCa-2).
  • 2-ME-induced apoptosis is mitochondria-dependent, involving cytochrome c release, Bid cleavage, and Bax translocation to mitochondria, with Bcl-x(L) phosphorylation observed in G2-M arrested cells.

Conclusions:

  • 2-ME effectively induces apoptosis in a subset of human pancreatic cancer cells through distinct, yet interconnected, molecular pathways.
  • The differential response suggests that targeting specific apoptotic regulators could enhance 2-ME's therapeutic efficacy in pancreatic cancer.
  • Understanding these signaling cascades is crucial for developing novel therapeutic strategies against pancreatic cancer.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...